You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. IGF OT IGF A SHARED DECISION MAKING TOOL TO PREVENT SUBSTANCE ABUSE N DA PERIOD OF PERFORMANCE SEPTEMBER MARCH BASE AWARD

    SBC: RINGFUL LLC            Topic: NIDA

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  2. IGF OT IGF I CLR AS A NEO ADJUVANT TREATMENT OPTION FOR TRIPLE NEGATIVE BREAST CANCER PERIOD OF PERFORMANCE

    SBC: Cellectar Biosciences, Inc.            Topic: NCI

    Poor prognosis of triple negative breast cancer TNBC is attributable to the absence of efficacious molecularly targeted neoadjuvant therapies Micrometastases contribute to poor prognosis by increasing recurrence rate Consequently an effective treatment option that is capable of targeting and sterilizing micrometastatic disease in patients with TNBC is warranted I CLR is proposed as ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF IN VITRO CANCER STEM CELL EXPANSION PROGRAM FOR RARE TUMOR TYPES PERIOD OF PERFORMANCE

    SBC: KIYATEC, LLC            Topic: NCI

    The overall objective of this proposal is to develop an in vitro process by which cancer stem cells CSC can be isolated from primary human tumor biopsies or tissues expanded without losing critical elements of stem cell qualities and then used for preclinical and clinical applications During this fast track proposal KIYATEC will employ an integrated functional and unbiased scientific strate ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF EVORX TECHNOLOGIES INC

    SBC: EVORX TECHNOLOGIES, INC.            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  5. IGF OT IGF SBIR TOPIC

    SBC: MODULATION THERAPEUTICS, INC.            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. SBIR PHASE I RADIONUCLIDE THERAPY FOR METASTATIC MELANOMA VIEWPOINT MOLECULAR TARGETING LLC IGF OT IGF

    SBC: VIEWPOINT MOLECULAR TARGETING, INC.            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. IGF OT IGF "SBIR PHASE I NEW D HUBIOGEL CULTURE SYSTEM FOR CANCER STEM CELLS EXPANSION and ANALYSIS"

    SBC: Vivo Biosciences Inc            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. IGF OT IGF DEVELOPMENT OF AN INNOVATIVE PSMA TARGETED RADIONUCLIDE THERAPY FOR PROSTATE CANCER PERIOD OF PERFORMANCE

    SBC: Cancer Targeted Technology LLC            Topic: NCI

    Background Information The Phase II of the contract has four objectives Objective Scale up and analytical characterization of the lead radiotherapeutic agent selected from Phase I Objective Optimization of dose regimen in an animal efficacy model using a PSMA expressing subcutaneous human prostate tumor Objective Maximum Tolerate Dose Study of Lead Lu DOTA PSMA therapeutic agent ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. IGF OT IGF SBIR PHASE TOPIC

    SBC: AKRIVIS TECHNOLOGIES, LLC            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. IGF OT IGF ANGIOCRINE BIOSCIENCE INC

    SBC: Angiocrine Bioscience            Topic: NCI

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government